Sisira Yadala
Associate Professor
faculty
Neurology, College of Medicine
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Sisira Yadala's research focuses on the diagnosis and management of epilepsy and related neurological conditions. Her clinical interests include treating refractory epilepsy, utilizing video EEG and invasive EEG monitoring, and performing pre-surgical evaluations for epilepsy surgery. She also investigates neuro-modulation techniques using devices such as Vagal Nerve Stimulators (VNS), Responsive Neurostimulation (RNS), and Deep Brain Stimulation (DBS). Her work extends to understanding epilepsy in women and the neurological impacts of various medical conditions, including COVID-19 and its treatments.
Dr. Yadala has contributed to publications examining the underutilization of stroke care during the COVID-19 pandemic and exploring predictors of no-show appointments in neurology clinics. She has also published on the use of everolimus for refractory seizures in tuberous sclerosis and reviewed cases of thrombotic thrombocytopenic purpura (TTP) following COVID-19 vaccination. Her expertise is further demonstrated by her work on vagus nerve stimulation for epilepsy management and discussions on learning from failures in anterior temporal lobectomies.
Her scholarly contributions are reflected in an h-index of 7 with over 40 publications and 412 citations. Dr. Yadala collaborates with researchers including Krishna Nalleballe, Sen Sheng, Salman Zahoor, and Mudassar Kamran, primarily within the University of Arkansas system.
Research Overview
Dr. Sisira Yadala is an Assistant Professor of Neurology and Director of the Division of Epilepsy and Level 4 Comprehensive Epilepsy Center at the University of Arkansas for Medical Sciences (UAMS). Dr. Yadala is board certified by the Board of Psychiatry and Neurology in both Neurology and Epilepsy. Dr. Yadala graduated from Osmania Medical College, Hyderabad, India in 2007. She then completed a Preliminary Internal Medicine Residency at West Lake Hospital, Resurrection Health Systems, Melrose Park, Illinois in 2010 prior to joining the Temple University Hospital in Philadelphia, Pennsylvania where she completed her Neurology Residency in 2013, followed by completion of a Epilepsy/Clinical Neurophysiology Fellowship at New York University, New York, New York in 2014. Dr.Yadala’s expertise and clinical interests include management of refractory epilepsy (difficult to control epilepsy) , Video EEG monitoring, Invasive EEG monitoring, Pre-surgical evaluation for epilepsy surgery, Neuro-modulation with devices such as VNS (Vagal Nerve Stimulator), RNS (Responsive Neurostimulation) and DBS (Deep Brain Stimulation) and Epilepsy in women. Dr.Yadala treats patients at the Freeway Epilepsy and Neurology clinic.
Metrics
- h-index: 7
- Publications: 40
- Citations: 417
Selected Publications
-
Learning From Our Failures: When Anterior Temporal Lobectomies Fail (2026)
-
Acute Disruption of Cortical Epileptiform Discharges With Thalamic Stimulation (2025)
-
Vagus nerve stimulation for the management of epilepsy (2024)
-
Approach to patients with autoimmune encephalitis with no identifiable antibodies (P2-1.001) (2022)
-
Everolimus for Treatment of Refractory Seizures in Tuberous Sclerosis (P3-8.002) (2022)
-
A case report of Granulomatous angiitis associated with Cogan syndrome. (P12-1.002) (2022)
-
Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases (2022)
-
Predictors of No-Show in Neurology Clinics (2022)
-
Continued Underutilization of stroke care during the COVID-19 pandemic (2021)
-
A 44-Year-Old Woman With a 10-Year History of Dyspnea and Pulmonary Nodules (2021)
-
Neuroanatomy, Corticobulbar Tract (2021)3 citations OpenAlex
-
EEG Benign Variants (2021)
Grants & Funding
- A double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of intravenous ganaxolone in status epilepticus (IRB 262680) Marinus Pharmaceuticals Principal Investigator
- A double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of intravenous ganaxolone in status epilepticus (IRB 262680) Marinus Pharmaceuticals Principal Investigator
Collaboration Network
Top Collaborators
- Predictors of No-Show in Neurology Clinics
- Continued Underutilization of stroke care during the COVID-19 pandemic
- EEG Benign Variants
- Neuropsychiatric Manifestations in COVID - 19 (1282)
- [Figure, Fig 1 EEG showing 3-3.5...]
Showing 5 of 11 shared publications
- Predictors of No-Show in Neurology Clinics
- Continued Underutilization of stroke care during the COVID-19 pandemic
- EEG Benign Variants
- [Figure, Figure 4. Example of 14-...]
- [Figure, Figure 1. BSSS (aka BETS)...]
Showing 5 of 8 shared publications
- Predictors of No-Show in Neurology Clinics
- Continued Underutilization of stroke care during the COVID-19 pandemic
- Neuropsychiatric Manifestations in COVID - 19 (1282)
- Snowball effect of COVID-19: Stroke Care Underutilization (P1-1.Virtual)
- Immunosuppression in Chronic Autoimmune Neurological Disorders during the COVID-19 Pandemic (P13-1.001)
- Predictors of No-Show in Neurology Clinics
- Neuropsychiatric Manifestations in COVID - 19 (1282)
- [Figure, Temporal Schizencephaly, MRI of a...]
- Predictors of No-Show in Neurology Clinics
- Neuropsychiatric Manifestations in COVID - 19 (1282)
- Immunosuppression in Chronic Autoimmune Neurological Disorders during the COVID-19 Pandemic (P13-1.001)
- Neuropsychiatric Manifestations in COVID - 19 (1282)
- [Figure, Temporal Schizencephaly, MRI of a...]
- Immunosuppression in Chronic Autoimmune Neurological Disorders during the COVID-19 Pandemic (P13-1.001)
- Predictors of No-Show in Neurology Clinics
- Neuropsychiatric Manifestations in COVID - 19 (1282)
- Immunosuppression in Chronic Autoimmune Neurological Disorders during the COVID-19 Pandemic (P13-1.001)
- Everolimus for Treatment of Refractory Seizures in Tuberous Sclerosis (P3-8.002)
- A case report of Granulomatous angiitis associated with Cogan syndrome. (P12-1.002)
- Approach to patients with autoimmune encephalitis with no identifiable antibodies (P2-1.001)
- Everolimus for Treatment of Refractory Seizures in Tuberous Sclerosis (P3-8.002)
- A case report of Granulomatous angiitis associated with Cogan syndrome. (P12-1.002)
- Acute Disruption of Cortical Epileptiform Discharges With Thalamic Stimulation
- Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases
- A 44-Year-Old Woman With a 10-Year History of Dyspnea and Pulmonary Nodules
- Continued Underutilization of stroke care during the COVID-19 pandemic
- Approach to patients with autoimmune encephalitis with no identifiable antibodies (P2-1.001)
- Continued Underutilization of stroke care during the COVID-19 pandemic
- Snowball effect of COVID-19: Stroke Care Underutilization (P1-1.Virtual)
- Continued Underutilization of stroke care during the COVID-19 pandemic
- Snowball effect of COVID-19: Stroke Care Underutilization (P1-1.Virtual)
- Continued Underutilization of stroke care during the COVID-19 pandemic
- Neuropsychiatric Manifestations in COVID - 19 (1282)
- Predictors of No-Show in Neurology Clinics
- Neuropsychiatric Manifestations in COVID - 19 (1282)
Similar Researchers
Based on overlapping research topics